Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system (Q30573765)

21 August 2017

Active safety monitoring of newly marketed medications in a distributed data network: application of a semi-automated monitoring system (English)

1 reference

21 August 2017

1 reference

Sebastian Schneeweiss

7

object named as

S Schneeweiss

1 reference

21 August 2017

2

R J Glynn

1 reference

21 August 2017

1

J J Gagne

1 reference

21 August 2017

J A Rassen

3

1 reference

21 August 2017

A M Walker

4

1 reference

21 August 2017

G W Daniel

5

1 reference

21 August 2017

G Sridhar

6

1 reference

21 August 2017

language of work or name

English

0 references

publication date

16 May 2012

1 reference

Clinical Pharmacology & Therapeutics

21 August 2017

1 reference

21 August 2017

92

1 reference

21 August 2017

1

1 reference

21 August 2017

80-86

1 reference

Active safety monitoring of new medical products using electronic healthcare data: selecting alerting rules

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

An event-based approach for comparing the performance of methods for prospective medical product monitoring.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Use of multiple international healthcare databases for the detection of rare drug‐associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Privacy-maintaining propensity score-based pooling of multiple databases applied to a study of biologics.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Statin therapy and risk of developing type 2 diabetes: a meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Risk of hepatotoxicity associated with the use of telithromycin: a signal detection using data mining algorithms

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Telithromycin use and spontaneous reports of hepatotoxicity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Risk factors for statin-associated rhabdomyolysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48,000 initiators of statin therapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

A review of uses of health care utilization databases for epidemiologic research on therapeutics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Health plan administrative databases can efficiently identify serious myopathy and rhabdomyolysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3947906

Developing the Sentinel System--a national resource for evidence development

28 July 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2011.369

Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2011.369

Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2011.369

Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2011.369

Dangers of rosuvastatin identified before and after FDA approval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2011.369

The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2011.369

Design considerations in an active medical product safety monitoring system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2011.369

A basic study design for expedited safety signal evaluation based on electronic healthcare data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2011.369

Are claims data accurate enough to identify patients for performance measures or quality improvement? The case of diabetes, heart disease, and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2011.369

Results from a rosuvastatin historical cohort study in more than 45 000 Dutch statin users, a PHARMO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/CLPT.2011.369

The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs

21 January 2018

1 reference

12 December 2020

Comparison of potentially hepatotoxic drugs among major US drug compendia

1 reference

12 December 2020

The New Sentinel Network — Improving the Evidence of Medical-Product Safety

1 reference

12 December 2020

Managing drug-risk information--what to do with all those new numbers

1 reference

12 December 2020

What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research

1 reference

12 December 2020

Identifiers

DOI

10.1038/CLPT.2011.369

1 reference

Dimensions Publication ID

21 August 2017

0 references

1 reference

21 August 2017

PubMed publication ID

22588606

1 reference